Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells

Leukemia

Volumn 12, Issue 5, 1998, Pages 637-644

  Sattler, M ^a   Salgia, R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

BCR ABL; CRK; CRKL; Cytoskeleton; Hematopoietic growth factor; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; BCR ABL PROTEIN; ERYTHROPOIETIN; INTEGRIN; PAXILLIN; PHOSPHOPROTEIN; STEEL FACTOR; T LYMPHOCYTE RECEPTOR; THROMBOPOIETIN;

AMINO TERMINAL SEQUENCE; CELL TRANSFORMATION; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031946385     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401010     Document Type: Review

References (13)

1. ten Hoeve J, Morris C, Heisterkamp N, Groffen J. Isolation and chromosomal localization of CRKL, a human Crk-like gene. Oncogene 1993; 8: 2469-2474.
2. Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 1994; 269: 22925-22928.
3. Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P, Golde DW. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood 1994; 84: 2912-2918.
4. + leukemia. Blood 1994; 84: 1731-1736.
5. Reichman CT, Mayer BJ, Keshav S, Hanafusa H. The product of the cellular Crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ 1992; 3: 451-460.
6. Morris C, Benjes S, Haataja L, Ledbetter DH, Heisterkamp N, Groffen J. Spatial organization of ABR and CRK genes on human chromosome band 17p13.3. Oncogene 1995; 10: 1009-1011.
7. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 1992; 12: 3482-3489.
8. Mayer BJ, Hamaguchi M, Hanafusa H. A novel viral oncogene with structural similarity to phospholipase C. Nature 1988; 332: 272-275.
9. Feller SM, Knudsen B, Hanafusa H. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J 1994; 13: 2341-2351.
10. Oda A, Miyakavva Y, Druker BJ, Ishida A, Ozaki K, Ohashi H, Wakui M, Handa M, Watanabe K, Okamoto S, Ikeda Y. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. Blood 1996; 88: 4304-4313.
11. Barber DL, Mason JM, Fukazawa T, Reedquist KA, Druker BJ, Band H, Dandrea AD. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of Cbl and association with Crk adaptor proteins. Blood 1997; 89: 3166-3174.
12. Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad K, Griffin JD. Steel factor induces tyrosine phosphorylation of Crkl and binding of Crkl to a complex containing c-Kit, phosphatidylinositol 3-kinase, and p120Cbl. J Biol Chem 1997; 272: 10248-10253.
13. Feng S, Chen JK, Yu H, Simon JA, Schreiber SL. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 1994; 266: 1241-1247.